Swindon, UK Site Tour Video
Catalent’s Swindon, UK facility, located 85 miles west of central London, is the manufacturing center for Catalent’s Zydis® Orally Disintegrating Tablet (ODT) platform. Equipped with high-speed manufacturing suites, the site produces approximately 1.2B doses per year and supports both Rx and OTC products as well as potent and controlled substances.
With more than 35 products launched in over 60 countries, the Zydis® ODT technology is the world’s best-in-class ODT technology. The Zydis fast-dissolve platform consists of three technologies: Zydis ODT, Zydis Ultra®, and Zydis Bio. Zydis ODT is a unique freeze-dried oral solid dosage form with almost instant oral dispersion, typically less than three seconds, without the need for water. Zydis Ultra technology offers enhanced taste-masking capabilities, increased drug loading, and the potential for functional coating. Zydis Bio technology offers a formulation strategy for oral delivery of peptides, allergens, and viral vaccines.